Triplex Digital PCR Assays for the Quantification of Intact Proviral HIV-1 DNA
Overview
Authors
Affiliations
The development of an HIV-1 cure is hampered by the existence of a persistent (latent) reservoir that contains a small proportion of replication-competent intact proviruses which refuels viral replication upon treatment discontinuation. Therefore, an accurate evaluation and quantification of these (intact) proviruses is essential to determine the efficacy of HIV-1 cure strategies which aim to eliminate this reservoir. Here, we present two triplex digital PCR assays which resulted from a combination of two existing methods, the IPDA (a 2-colour digital PCR based method) and Q4PCR assays (4 colour qPCR method), and tested the functionality on a three-colour digital PCR platform. In the present paper, we provide a step-by-step experimental protocol for these triplex digital PCR assays and validate their performance on a latently infected Jurkat cell-line model and HIV-1 patient samples. Our data demonstrates the potential and flexibility of increasing the number of subgenomic regions of HIV-1 within the IPDA to acquire sensitive detection of the HIV-1 reservoir while benefitting from the advantages of a dPCR setup.
Braun T, Rade M, Merz M, Klepzig H, Grosse F, Fandrei D Nat Med. 2025; .
PMID: 39984633 DOI: 10.1038/s41591-025-03499-9.
Duong T, Firmo M, Li C, Gu B, Wang P Sci Rep. 2025; 15(1):2154.
PMID: 39820513 PMC: 11739598. DOI: 10.1038/s41598-024-77378-7.
Specific quantification of inducible HIV-1 reservoir by RT-LAMP.
Hossain T, Lungu C, de Schrijver S, Kuali M, Crespo R, Reddy N Commun Med (Lond). 2024; 4(1):123.
PMID: 38918506 PMC: 11199587. DOI: 10.1038/s43856-024-00553-4.
Benchmarking digital PCR partition classification methods with empirical and simulated duplex data.
Chen Y, De Spiegelaere W, Trypsteen W, Gleerup D, Vandesompele J, Lievens A Brief Bioinform. 2024; 25(3).
PMID: 38555473 PMC: 10981767. DOI: 10.1093/bib/bbae120.
Development of a highly sensitive and specific intact proviral DNA assay for HIV-1 subtype B and C.
Buchholtz N, Nuhn M, de Jong T, Stienstra T, Reddy K, Ndungu T Virol J. 2024; 21(1):36.
PMID: 38297379 PMC: 10832250. DOI: 10.1186/s12985-024-02300-6.